Chromicent GmbH is a pharmaceutical service provider for chromatographic method development and pharmaceutical analysis. more…

Specialized in: Quality by Design (QbD) and Method LifeCycle Management (MLCM). more…

Services

Method Development

Robust, safe, effective methods using QbD and MLCM

Transfer

Optimal method transfer through knowledge management report & employee training

Troubleshooting

Analytical problem solving & robustness testing of established chromatographic methods

Consulting

Experience meets innovation: Advice on technical and regulatory issues

News from Chromicent

• 
  The Chromicent at a glanceMarch 2022
  Dear customers and friends of Chromicent, the comprehensive Chromicent portfolio at a glance. Of course also available as PDF for download:
• 
  News from the ChromicentFebruary 2022
  Dear customers and friends of Chromicent, We hope you have had a good start to 2022. At Chromicent, the start of the new year is marked by challenges and exciting … News from the Chromicent
• 
  Nitrosamine – New publicationFebruary 2022
  Nitrosamines continue to be an important topic in drug safety. Chromicent conducts intensive research in this area and thus makes its contribution to drug suply safety and prevention of drug … Nitrosamine – New publication
• 
  European Extractables and Leachables ForumJanuary 2022
  The migration of potential harmful substances from packaging materials is one of the central issues in health protection. This concerns manufacturers of pharmaceutical products as well as producers and distributors … European Extractables and Leachables Forum

Publications